Bangladesh vs Zambia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Bangladesh
0.4%
in 2024
Zambia
0.4%
in 2024
Bangladesh rank
74th
Zambia rank
74th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Bangladesh
- Zambia
How they compare
Bangladesh currently reports 0.4% against 0.4% in Zambia, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Zambia ahead.
Bangladesh ranks 74th and Zambia ranks 74th of 246 countries.
Bangladesh has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.7% | 0.6% | 0.1% | Bangladesh |
| 2020s | 0.5% | 0.4% | 0.1% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bangladesh or Zambia?
- Bangladesh, at 0.4% against 0.4% in Zambia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bangladesh and Zambia?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Zambia?
- 10 years are reported by both, from 2015 to 2024.
- How do Bangladesh and Zambia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Bangladesh ranks 74th and Zambia ranks 74th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.